Toxicological assessment of gadolinium release from contrast media

Experimental and Toxicologic Pathology

Volumn 58, Issue 5, 2007, Pages 323-330

  Bussi, Simona ^a   Fouillet, Xavier ^b   Morisetti, Alberto ^a  

^a Bracco Imaging SpA   (Italy)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Gadolinium acetate; Gadolinium release; ICP; Intravenous; Rat

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM ACETATE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BONE LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG LIVER LEVEL; DRUG RELEASE; EVALUATION; FEMUR; HUMAN; KIDNEY; LEUKOCYTE COUNT; LYMPHATIC SYSTEM; NONHUMAN; PERIARTERIOLAR LYMPHATIC SHEATH; RAT; SPLEEN; SPRAGUE DAWLEY RAT; TOXICITY TESTING;

RATTUS;

EID: 33947692824     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.09.003     Document Type: Article

References (20)

1. Cacheris W.P., Quay S.C., and Rocklage S.M. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imag 8 (1990) 467-481
2. de Haën C., Lorusso V., and Tirone P. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. Acta Radiol 2 (1995) 232-238
3. de Haën C., Lorusso V., and Tirone P. Hepatic transport in TR- rats of the MRI contrast agent gadobenate dimeglumine. Acta Radiol 3 (1996) S452-S454
4. de Haën C., Cabrini M., Aknana L., Ratti D., Calabi L., and Gozzini L. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance®): pharmaceutical formulation and physico-chemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 Suppl 1 (1999) S161-S168
5. Evans CH. Biochemistry of the lanthanides. New York: Plenum Press; 1990. p. 339-417.
6. Gemery J., Idelson B., Reid S., Yucel E.K., Pagan Marin H., Ali S., et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol 171 (1998) 1277-1278
7. Hall R.L. Principles of clinical pathology for toxicology studies. In: Hayes A.W. (Ed). Principles and methods of toxicology (2001), Taylor & Francis Publishers, Philadelphia 1001-1038
8. Harpur E.S., Worah D., Hals P.A., Holtz E., Furuhama K., and Nomura H. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28 (1993) S28-S43
9. Kasokat T., and Urich K. Quantification of dechelation of gadopentetate dimeglumine in rats. Arzneimittelforschung 42 6 (1992) 869-876
10. Kirchin M.A., and Runge V.M. Contrast gents for magnetic resonance imaging: safety update. Top Magn Reson Imag 14 (2003) 426-435
11. Lorusso V., Pascolo L., Ferretti C., Anelli P.L., Uggeri F., and Tiribelli C. Magnetic resonance contrast agents: from the bench to the patient. Curr Pharmaceut Des 11 (2005) 4079-4098
12. Morisetti A., Bussi S., Tirone P., and de Haën C. Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance®), a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 Suppl 1 (1999) S207-S217
13. Murphy K.P.J., Szopinski K.T., Cohan R.H., Mermillod B., and Ellis J.H. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol 6 (1999) 656-664
14. Niendorf H.P., Alhassan A., Geens V.R., and Clauss W. Safety review of gadopentetate dimeglumine: extended clinical experience after more than five million applications. Invest Radiol 29 (1994) S179-S182
15. Runge V.M., Bradley W.G., Brant-Zawadzki M.N., Carvlin M.J., DeSimone D.N., Dean B.L., et al. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Radiology 181 3 (1991) 701-709
16. Spencer A.J., Wilson S.A., Batchelor J., Reid A., Rees J., and Harpur E. Gadolinium chloride toxicity in the rat. Toxicol Pathol 25 (1997) 245-255
17. Terzi C., and Sokmen S. Acute pancreatitis induced by magnetic-resonance-imaging contrast agent. Lancet 354 (1999) 1789-1790
18. Tombach B., and Heindel W. Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 12 6 (2002) 1550-1556
19. Vargas MH. InerSTAT-a v1.3 - simple statistics tool for Excel. Instituto Nacional de Enfermedades Respiratorias, Hospital General "Dr. Manuel Gea González", Mexico, 1999.
20. Wedeking P., and Tweedle M. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice. Nucl Med Biol 15 (1988) 395-402